SEI Investments’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $109M | Sell |
572,746
-111,006
| -16% | -$20.9M | 0.1% | 216 |
|
|
2026
Q1 | $135M | Buy |
683,752
+200,634
| +42% | +$38.7M | 0.12% | 169 |
|
|
2025
Q4 | $88.8M | Buy |
483,118
+124,481
| +35% | +$21.8M | 0.09% | 235 |
|
|
2025
Q3 | $55M | Sell |
358,637
-48,448
| -12% | -$7.33M | 0.06% | 326 |
|
|
2025
Q2 | $56.9M | Sell |
407,085
-438
| -0.1% | -$61.4K | 0.07% | 312 |
|
|
2025
Q1 | $59.9M | Buy |
407,523
+26,050
| +7% | +$3.77M | 0.08% | 286 |
|
|
2024
Q4 | $50M | Sell |
381,473
-72,094
| -16% | -$10.1M | 0.06% | 321 |
|
|
2024
Q3 | $70.7M | Buy |
453,567
+13,844
| +3% | +$2.23M | 0.09% | 238 |
|
|
2024
Q2 | $68.6M | Buy |
439,723
+39,294
| +10% | +$5.91M | 0.1% | 222 |
|
|
2024
Q1 | $54.3M | Sell |
400,429
-2,225
| -0.6% | -$295K | 0.08% | 271 |
|
|
2023
Q4 | $54.2M | Sell |
402,654
-102,636
| -20% | -$13.3M | 0.09% | 241 |
|
|
2023
Q3 | $68.4M | Buy |
505,290
+34,827
| +7% | +$4.76M | 0.12% | 149 |
|
|
2023
Q2 | $67.3M | Sell |
470,463
-237,864
| -34% | -$35M | 0.12% | 155 |
|
|
2023
Q1 | $98.3M | Buy |
708,327
+10,775
| +2% | +$1.45M | 0.18% | 96 |
|
|
2022
Q4 | $94.6M | Buy |
697,552
+152,635
| +28% | +$19.1M | 0.21% | 84 |
|
|
2022
Q3 | $59.8M | Buy |
544,917
+155,404
| +40% | +$19.7M | 0.13% | 141 |
|
|
2022
Q2 | $51.6M | Buy |
389,513
+59,004
| +18% | +$7.74M | 0.11% | 175 |
|
|
2022
Q1 | $43.9M | Buy |
330,509
+31,689
| +11% | +$3.8M | 0.09% | 236 |
|
|
2021
Q4 | $34.9M | Sell |
298,820
-16,126
| -5% | -$1.9M | 0.07% | 311 |
|
|
2021
Q3 | $37.8M | Sell |
314,946
-12,398
| -4% | -$1.44M | 0.08% | 263 |
|
|
2021
Q2 | $39.4M | Sell |
327,344
-4,635
| -1% | -$509K | 0.09% | 230 |
|
|
2021
Q1 | $33.2M | Sell |
331,979
-257,110
| -44% | -$25.8M | 0.08% | 240 |
|
|
2020
Q4 | $59.1M | Sell |
589,089
-5,991
| -1% | -$635K | 0.15% | 118 |
|
|
2020
Q3 | $65.3M | Sell |
595,080
-77,279
| -11% | -$8.6M | 0.19% | 95 |
|
|
2020
Q2 | $71.3M | Sell |
672,359
-49,280
| -7% | -$5.09M | 0.22% | 82 |
|
|
2020
Q1 | $64.4M | Buy |
721,639
+8,585
| +1% | +$808K | 0.24% | 74 |
|
|
2019
Q4 | $71.1M | Sell |
713,054
-68,173
| -9% | -$6.42M | 0.21% | 75 |
|
|
2019
Q3 | $69.6M | Buy |
781,227
+18,300
| +2% | +$1.59M | 0.18% | 92 |
|
|
2019
Q2 | $63.1M | Buy |
762,927
+73,308
| +11% | +$5.75M | 0.21% | 80 |
|
|
2019
Q1 | $55.8M | Buy |
689,619
+122,223
| +22% | +$9.63M | 0.19% | 97 |
|
|
2018
Q4 | $44.6M | Buy |
567,396
+4,697
| +0.8% | +$367K | 0.16% | 117 |
|
|
2018
Q3 | $44.6M | Sell |
562,699
-96,287
| -15% | -$7.28M | 0.16% | 111 |
|
|
2018
Q2 | $46.3M | Buy |
658,986
+491,527
| +294% | +$35.4M | 0.16% | 116 |
|
|
2018
Q1 | $11.7M | Sell |
167,459
-351,471
| -68% | -$24.3M | 0.04% | 439 |
|
|
2017
Q4 | $36.4M | Buy |
518,930
+14,287
| +3% | +$963K | 0.13% | 154 |
|
|
2017
Q3 | $34.8M | Sell |
504,643
-27,178
| -5% | -$1.72M | 0.12% | 163 |
|
|
2017
Q2 | $36.3M | Buy |
531,821
+39,148
| +8% | +$2.56M | 0.14% | 146 |
|
|
2017
Q1 | $30.7M | Buy |
492,673
+178,804
| +57% | +$10.4M | 0.13% | 166 |
|
|
2016
Q4 | $17.4M | Sell |
313,869
-14,079
| -4% | -$799K | 0.08% | 298 |
|
|
2016
Q3 | $21.6M | Buy |
327,948
+143,532
| +78% | +$9.38M | 0.11% | 222 |
|
|
2016
Q2 | $11.1M | Buy |
184,416
+49,070
| +36% | +$2.85M | 0.07% | 372 |
|
|
2016
Q1 | $7.62M | Buy |
135,346
+81,117
| +150% | +$4.87M | 0.05% | 474 |
|
|
2015
Q4 | $3.68M | Buy |
54,229
+39,941
| +280% | +$2.62M | 0.02% | 763 |
|
|
2015
Q3 | $909K | Sell |
14,288
-154
| -1% | -$10.1K | 0.01% | 1073 |
|
|
2015
Q2 | $920K | Sell |
14,442
-4
| -0% | -$274 | 0.01% | 1005 |
|
|
2015
Q1 | $987K | Sell |
14,446
-53
| -0.4% | -$3.68K | 0.01% | 977 |
|
|
2014
Q4 | $1.02M | Buy |
+14,499
| New | +$1.04M | 0.01% | 939 |
|
Other funds holding AZN
EP
IA
SEI Investments's AZN Position: Q2 2026 in Review
SEI Investments reduced its AstraZeneca (AZN) stake by 16% in Q2 2026, selling an estimated $20.9M and leaving 572,746 shares worth $109M. The position accounts for 0.1% of the portfolio, ranked #216.
SEI Investments first reported a position in AZN in Q4 2014 and has held it in 47 quarters since. The position peaked at $135M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- SEI Investments held 572,746 shares of AstraZeneca worth $109M as of Q2 2026.
- SEI Investments sold 111,006 AstraZeneca shares in Q2 2026, an estimated $20.9M.
- AstraZeneca made up 0.1% of SEI Investments's portfolio in Q2 2026, its #216 holding.
- SEI Investments first reported a position in AstraZeneca in Q4 2014 and has held it in 47 quarters since.
- SEI Investments's AstraZeneca position peaked at $135M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.